Patents by Inventor Carsten Materne

Carsten Materne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4380547
    Abstract: The invention relates to dihydropyridine compounds of formula (I) as defined in the specification, containing a hetero-ring substituent in the 4-position. Also included in the invention are pharmaceutical compositions containing said compounds of formula (I) and methods for the use of said compounds and compositions. The said compounds are useful for influencing circulation.
    Type: Grant
    Filed: May 29, 1981
    Date of Patent: April 19, 1983
    Assignee: Bayer Aktiengesellschaft
    Inventor: Carsten Materne
  • Patent number: 4364952
    Abstract: The invention relates to 1,4-dihydropyridines which carry an arylalkyl or aryloxyalkyl radical in the 4-position. Also included in the invention are methods for the preparation of said compounds. The invention further relates to compositions containing said 1,4-dihydropyridines and the use of said compounds and compositions for their circulation influencing effects.
    Type: Grant
    Filed: May 29, 1981
    Date of Patent: December 21, 1982
    Assignee: Bayer Aktiengesellschaft
    Inventor: Carsten Materne
  • Patent number: 4351837
    Abstract: The invention relates to 1,4-dihydropyridine-4-carboxylic acid amines of the formula (I) as defined in the specification. Also included in the invention are methods for the preparation of said compounds. The invention further relates to compositions containing said 1,4-dihydropyridines and the use of said compounds and compositions for their circulation influencing effects.
    Type: Grant
    Filed: May 22, 1981
    Date of Patent: September 28, 1982
    Assignee: Bayer Aktiengesellschaft
    Inventor: Carsten Materne
  • Patent number: 4341790
    Abstract: 2-Oxo-1-pyrrolidinylalkylcarboxylic acid amides of formula I ##STR1## in which R represents a hydrogen atom or hydroxy group, R.sub.1 represents a hydrogen atom or a methyl group and R.sub.2 represents a substituted or unsubstituted pyridyl group or a substituted phenyl group, the substitution being by from 1 to 3 substituents, which may be the same or different selected from halogen atoms, trifluoromethyl, nitro and acetyl groups, straight or branched-chain alkyl groups having 1-4 carbon atoms, alkoxy groups having 1-4 carbon atoms, straight or branched-chain alkylmercapto groups having 1-7 carbon atoms, substituted alkylmercapto groups of the general formula II ##STR2## in which n represents 1 or 2, R.sub.3 is a hydrogen atom or a methyl group and R.sub.4 is a hydroxy group or an amino group of the general formula V ##STR3## in which R.sub.8 represents a hydrogen atom or methyl group and R.sub.9 represents a methyl group or substituted or unsubstituted benzyl group, or R.sub.8 and R.sub.
    Type: Grant
    Filed: June 3, 1980
    Date of Patent: July 27, 1982
    Assignee: A. Nattermann & Cie. GmbH
    Inventors: Hans Betzing, Jurgen Biedermann, Carsten Materne, Volker Neuser
  • Patent number: 4277483
    Abstract: The present invention is related to the new 2.6-dimethyl-4-(3'-nitrophenyl)-1.4-dihydropyridine-3-carboxylic acid beta-trimethylsilylethyl ester-5-carboxylic acid lower alkyl esters with improved antihypertensive and to a process for the treatment of humans suffering from hypertension with such compounds.
    Type: Grant
    Filed: April 14, 1980
    Date of Patent: July 7, 1981
    Assignee: A. Nattermann & Cie. GmbH
    Inventors: Carsten Materne, Hans Betzing